Morgan Stanley Venture Partners

Portfolio · 2

Tipalti

Automation for Supplier Payments

1 round $270.0M committed Latest: 2021-12

AID Cann

Medical Cannabis Products

1 round $30.0M committed Latest: 2001-10

Investment activity

1 portfolio exit on record.

Q&A

What is Morgan Stanley Venture Partners' most recent investment?

Morgan Stanley Venture Partners participated in Tipalti's F Round in December 2021. Tipalti is a B2B company focused on automation for supplier payments.

Which sectors does Morgan Stanley Venture Partners focus on for investments?

Morgan Stanley Venture Partners has invested in companies across the Health Tech & Life Sciences and Fintech & Insurtech sectors, with one investment in each.

What is a notable exit for Morgan Stanley Venture Partners?

Morgan Stanley Venture Partners had an exit with AID Cann in September 2009, when the company went public on the TASE stock exchange.

Can you name a portfolio company in the Health Tech & Life Sciences sector?

AID Cann, a company focused on medical cannabis products, is a portfolio company of Morgan Stanley Venture Partners in the Health Tech & Life Sciences sector.

What is the funding stage breakdown of Morgan Stanley Venture Partners' investments?

Morgan Stanley Venture Partners has participated in a D Round and an F Round, with one investment in each stage.

When was Morgan Stanley Venture Partners founded?

Morgan Stanley Venture Partners was created on May 11, 2019, according to startupim data.